Human Protein O-Glucosyltransferase 2 (POGLUT2) catalyzes the Oglucosylation of Notch receptors and extracellular matrix proteins, with its dysfunction linked to human disorders.Despite its physiological importance, the structural and mechanistic basis of POGLUT2 has remained elusive.Here, we report the first 1.79 structure of POGLUT2 in complex with UDP, revealing a three-domain architecture stabilized by an N-terminal Filamin-domain, which is unique in Notch-modifying enzymes.Integrated structural, computational and functional analyses demonstrate that POGLUT2 recognizes structural features J o u r n a l P r e -p r o o f within EGF repeats, including a conserved hydrophobic patch, which explains its stringent substrate selectivity.Our findings further identify Asp238 as the catalytic base, supporting an SN2-type inverting mechanism.Furthermore, we show that cancer-associated mutations impair enzymatic activity through distinct structural and mechanistic disruptions.By delineating conserved and divergent features between POGLUT2 and POGLUT1, our study advances the mechanistic understanding of EGF-repeat O-glucosylation and establishes a framework for investigating its dysregulation in human diseases.
Xia et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: